Focus Stocks
Mettler-Toledo - Traders Waiting for Entry
Published on Monday, 21 November 2011 18:36 Written by Christian Paolinetti
New York, November 21st (TradersHuddle.com) - Shares of Mettler-Toledo International Inc. (NYSE:MTD) closed the trading
day lower by $2.93 or -1.91% from its previous close. Mettler-Toledo's shares price action formed what is considered to be a
doji close, where the open and close prices are very close to each other, mainly signaling an indecision between buyers and sellers.
Mettler-Toledo International Inc. (NYSE:MTD) manufactures weighing instruments for use in laboratory, industrial, and food retailing applications. The Company also supplies several related analytical and measurement technologies.
Mettler-Toledo's current stock range is defined by a trough, which marks calculated support at $145.52 and by a peak that marked the resistance point at $167.59. These levels are closely watched by traders managing their positions.
Traders wanting to establish a position in Mettler-Toledo or traders that are already holding the stock can use the doji close to their advantage, since the pattern present a short term pause in the stock's price action. This pause results in an entry point for traders depending of which way the stock resolves this short term indecision.
Doji are important candlesticks that provide information on their own and as components in a number of important patterns. Doji form when a security's open and close are virtually equal. The length of the upper and lower shadows can vary and the resulting candlestick looks like a cross, inverted cross or plus sign. Alone, doji are neutral patterns.
Any bullish or bearish bias is based on preceding price action and future confirmation. In the case of Mettler-Toledo, given that the stock finished the session lower, bears should monitor the stock, as it could reverse if it manages to trade above today's intraday high. Below a Doji illustration:

Related Partner Headlines
- JP Morgan Maintains Mettler-Toledo International at Neutral, Raises PT from $166 to $180 - Benzinga
- Jefferies & Company Maintains Mettler-Toledo International at Buy, Raises PT from $200 to $205 - Benzinga
- Goldman Sachs Maintains Mettler-Toledo International at Buy, Raises PT from $187 to $194 - Benzinga
- Mettler-Toledo International Inc. (MTD): Today's Featured Health Care Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Stay Defensive - TheStreet.com -
United Rentals Stock Falls On Unusually High Volume (URI) - TheStreet.com -
Apollo Global Management Stock Falls On Unusually High Volume (APO) - TheStreet.com -
It's Crunch Time, and I Don't Mean Facebook - TheStreet.com -
JA Solar Holdings Co. ADR Stock Hits New 52-Week Low (JASO) - TheStreet.com -
Saba Software Stock Falls On Unusually High Volume (SABA) - TheStreet.com -
Dimon Will Testify Before Senate Commitee - TheStreet.com -
Can Amazon Prosper Without Profit? - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,442.49 Trade time:4:05PM EDT Value change:▼156.06 (-1.24%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,304.86 Trade time:4:20PM EDT Value change:▼19.94 (-1.51%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,813.69 Trade time:4:36PM EDT Value change:▼60.35 (-2.10%)In The Wires
-
FBL Financial Group Holds Annual Meeting and Declares Quarterly Dividend -
Vision-Sciences Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease -
Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout -
Oil States International, Inc. Announces Put Option Notification for 2 3/8% Contingent Convertible Senior Notes Due 2025 -
News International Scandal Sparks Concern about Business E-disclosure processes, New Survey Shows -
Gabelli Dividend & Income Trust Continues Monthly Distributions, Declaring Distributions of $0.08 Per Share -
Horizon Technology Finance Closes $1.5 Million Venture Loan to StreamBase -
Accelrys Announces Purchase of Cloud-based HEOS Drug Discovery Information Management Technology from SCYNEXIS










